6505--Amiodarone HCL Tablets
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), through its National Acquisition Center, intends to issue an unrestricted Request for Proposal (RFP) 36E79726R0014 for Amiodarone Hydrochloride (HCL) Tablets. This procurement will supply the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The VA plans to award one contract for a one-year base period with four one-year option periods. The RFP is expected to be issued on or about March 11, 2026, with a tentative closing date of March 25, 2026.
Scope of Work
This opportunity is for the procurement of Amiodarone HCL Tablets in 100 MG and 200 MG strengths. Estimated annual requirements:
- 100 MG Tablets (30 count bottles): 54,951 bottles
- 200 MG Tablets (60 count bottles): 108,834 bottles
- 200 MG Tablets (500 count bottles): 18,775 bottles
Key product requirements include:
- Offerors must state the exact drug name as it appears on the label and possess a unique NDC number.
- The successful offeror's label with its unique NDC shall be the only label on the product; VA labels must securely adhere over the contractor's label.
- Unit of use packaging (30 and 60 count bottles) must feature a safety cap (deshellable/convertible) and a bottle with a minimum 120cc volume, cylindrical body, 5.75" circumference, and fit a 5.25" x 2" label.
Contract & Timeline
- Contract Type: Unrestricted procurement, one contract award.
- Contract Period: One year base period plus four pre-priced one-year option periods.
- Distribution: Through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs.
- NAICS Code: 325412 (Drugs and Biologicals).
- Solicitation Issuance: On or about March 11, 2026.
- Tentative Closing Date: March 25, 2026.
- Published Date (Pre-solicitation): March 5, 2026.
Eligibility / Set-Aside
This is an unrestricted procurement. All responsible sources may submit an offer.
Submission & Evaluation
The solicitation, RFP 36E79726R0014, will be issued electronically in commercial item format in accordance with FAR Part 12. Interested offerors are advised to continuously monitor SAM.gov for any amendments or miscellaneous documents. No paper copies will be available.
Point of Contact
Deb Fassl, Contract Specialist Email: Deborah.Fassl@va.gov Phone: 708-856-5894